Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Alexander

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)|April 4, 2013
C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLCFaik Güntac Uzunoglu, Neda Yavari, Benjamin Alexander Bohn, et al.
Cancer Medicine|February 16, 2023
Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor-associated neurotoxicityNora Möhn, Susann Mahjoub, Laura Duzzi, et al.
American Journal of Respiratory and Critical Care Medicine|April 2, 2025
Oscillometry-defined Small Airway Dysfunction in Tobacco-exposed Adults with Impaired or Preserved AirflowMustafa Abdo, Henrik Watz, Frederik Trinkmann, et al.
Oncoimmunology|August 16, 2025
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsNora Möhn, Emily Narten, Laura Duzzi, et al.
Stroke|January 17, 2018
Cerebrovascular Disease Knowledge Portal: An Open-Access Data Resource to Accelerate Genomic Discoveries in StrokeKatherine M Crawford, Cristina Gallego-Fabrega, Christina Kourkoulis, et al.
Oncology Research|May 1, 2026
Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort StudyLaura Duzzi, Nora Möhn, Emily Narten, et al.
Cancer Medicine|January 26, 2025
Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG StudyJonas Paul Wiegmann, Tabea Fröhlich, Nora Möhn, et al.
Molecular Systems Biology|November 26, 2025
Decoding non-coding SNPs: systems genomics modelling dissects the heterogeneity of IBDDezső Módos, John P Thomas, Johanne Brooks-Warburton, et al.
Molecular Systems Biology|January 6, 2025
A multiplex method for rapidly identifying viral protease inhibitorsSeo Jung Hong, Samuel J Resnick, Sho Iketani, et al.
Journal of Clinical Medicine|June 26, 2025
Beyond the Scale: The Hidden Burden of Underweight and Cachexia in Adults with Congenital Heart Defects and Heart Failure-Results from the Pathfinder CHD-RegistryAnn-Sophie Kaemmerer-Suleiman, Sebastian Freilinger, Annika Freiberger, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|April 4, 2013
C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLCFaik Güntac Uzunoglu, Neda Yavari, Benjamin Alexander Bohn, et al.
Cancer Medicine|February 16, 2023
Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor-associated neurotoxicityNora Möhn, Susann Mahjoub, Laura Duzzi, et al.
American Journal of Respiratory and Critical Care Medicine|April 2, 2025
Oscillometry-defined Small Airway Dysfunction in Tobacco-exposed Adults with Impaired or Preserved AirflowMustafa Abdo, Henrik Watz, Frederik Trinkmann, et al.
Oncoimmunology|August 16, 2025
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsNora Möhn, Emily Narten, Laura Duzzi, et al.
Stroke|January 17, 2018
Cerebrovascular Disease Knowledge Portal: An Open-Access Data Resource to Accelerate Genomic Discoveries in StrokeKatherine M Crawford, Cristina Gallego-Fabrega, Christina Kourkoulis, et al.
Oncology Research|May 1, 2026
Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort StudyLaura Duzzi, Nora Möhn, Emily Narten, et al.
Cancer Medicine|January 26, 2025
Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG StudyJonas Paul Wiegmann, Tabea Fröhlich, Nora Möhn, et al.
Molecular Systems Biology|November 26, 2025
Decoding non-coding SNPs: systems genomics modelling dissects the heterogeneity of IBDDezső Módos, John P Thomas, Johanne Brooks-Warburton, et al.
Molecular Systems Biology|January 6, 2025
A multiplex method for rapidly identifying viral protease inhibitorsSeo Jung Hong, Samuel J Resnick, Sho Iketani, et al.
Journal of Clinical Medicine|June 26, 2025
Beyond the Scale: The Hidden Burden of Underweight and Cachexia in Adults with Congenital Heart Defects and Heart Failure-Results from the Pathfinder CHD-RegistryAnn-Sophie Kaemmerer-Suleiman, Sebastian Freilinger, Annika Freiberger, et al.
Pageof 5